Paclitaxel Inhibits Ovarian Tumor Growth by Inducing Epithelial Cancer Cells to Benign Fibroblast-like cells

Paclitaxel is commonly used to treat multiple human malignancies, but its mechanism of action is still poorly defined. Human ovarian cancer SKOV3 cells (parental SKOV3) were treated with paclitaxel (1 μM) for 2 days, and the morphologic changes in the cells were monitored for more than 4 months. Par...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Jia, Lizhou, Zhang, Shiwu, Ye, Yanfen, Li, Xin, Mercado-Uribe, Imelda, Bast, Robert C., Liu, Jinsong
פורמט: Artigo
שפה:Inglês
יצא לאור: 2012
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3495569/
https://ncbi.nlm.nih.gov/pubmed/22902993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2012.08.004
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים